While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

If you're in a relationship that faces struggles with weight and are considering GLP-1 medications like Ozempic, consider ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

Salveen Richter, Goldman Sachs lead U.S. biotech analyst, joins 'Squawk on the Street' to discuss Amgen's mid-stage trial ...

CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs ...

The Biden administration announcing Medicare and Medicaid coverage for medications such as Wegovy and Zepbound.

In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.